Delivery Order SPE2DB20D2014-SPE2DB24FB63L
Award Date
4/17/24
Potential Completion Date
4/18/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,451.30 delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens, a prescription medication used to treat type 2 diabetes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pen (3 mL), a medication used to treat type 2 diabetes. The Delivery Order has a ceiling value of $1,451.34 and a completion date of January 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a $2,948.28 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to manage diabetes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC allows...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,065.16 firm fixed price contract is for the provision of Ozempic 0.25-0.5 mg/dose pen 3 mL, a medication used for diabetes management. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,563.97 firm fixed-price delivery order is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,276.29, is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat type 2 diabetes. The contract has a firm fixed-price pricing type and an ultimate completion date of June 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat type 2 diabetes. The total ceiling value of the contract is $1,116.84, and it has a firm fixed-price pricing structure. The contract has an ultimate completion date of October 11, 2024. Amerisourcebergen holds a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $10,753.92 order is for the supply of Ozempic 0.25-0.5 mg/dose pens, a diabetes medication, with a completion date of February 29, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value...
This is a federal delivery order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,966.48 firm-fixed-price contract is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a medication used to treat type 2 diabetes. The award has an ultimate completion date of April 22, 2024. Amerisourcebergen Drug Corp is the corporate office division of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $2,207.10 award is for the supply of Ozempic 0.25-0.5 mg/dose pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...